Three years after its global market withdrawal and months after a negative advisory committee vote, GSK can officially call it a comeback for its multiple myeloma drug Blenrep in the U.S., albeit w | ...
Tesla said revenue from Full Self-Driving in the third quarter fell compared to the same period last year, when it brought in ...